ArticleThe Indian journal of medical research2025
Relationship between vitamin D deficiency, vitamin D receptor gene variants, & the risk of coronary artery disease among South Indians: A case-control study.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Vitamin D deficiency (VDD) and variations in the vitamin D receptor (VDR) gene are implicated in the pathogenesis of coronary artery disease (CAD). This study investigated the association between VDD, VDR gene variants (ApaI, BsmI, FokI, and TaqI), and CAD risk among South Indians. Methods The case-control study was conducted in 250 CAD patients and 260 matched controls. Serum vitamin D levels were measured by ELISA. Genotyping for VDR ApaI (A>C, rs7975232), BsmI (A>G, rs1544410), FokI (T>C, rs2228570), and TaqI (C>T, rs731236) was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results VDD was significantly higher among CAD patients (90%) than in controls (63%). Individuals with vitamin D levels <20 ng/ml were 5.7 times more likely to have CAD when compared to those with vitamin D levels ≥ 20 ng/ml (P<0.001, OR=5.74, 95% CI=2.92-11.30). No correlation was observed between vitamin D levels and CAD risk factors, systolic and diastolic blood pressure (r=-0.105, P=0.095, r=-0.049, P=0.437), and blood glucose (r=-0.067, P=0.304). A trend for negative correlation of vitamin D levels with cholesterol (r=-0.112, P=0.094) and triglyceride levels (r=-0.133, P=0.061) was observed. The VDR TaqI variant showed significant association with reduced CAD risk in the overall analysis (Model II, OR=0.60, 95% CI=0.39-0.90, P=0.016). The FokI variant was associated with an increased risk of CAD in males (Model III, OR=5.9, 95% CI=2.09-16.85, P=0.001). However, combined analysis of VDD and VDR gene variants indicated that neither FokI 'ff' (P=0.145) nor TaqI 'tt' (P=0.138) genotypes significantly altered CAD risk in vitamin D-deficient subjects. Interpretation & conclusions The findings of this study suggested that VDD was significantly higher among the CAD patients and increases the risk of CAD by 5.7-fold.This study revealed the differing roles of VDR gene variants in CAD susceptibility and the influence of gender and other covariates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.